Company Overview of HalioDx SAS
HalioDx SAS designs and develops in-vitro diagnostic products in the immuno-oncology field. The company offers a range of immune scoring tests. It offers ImmunoscoreCC, a decision making tool to clinicians for patients management based on anti-tumor immune response. HalioDx SAS was incorporated in 2014 and is based in Marseille, France.
Luminy Biotech Entreprises
163 Avenue de Luminy
Founded in 2014
33 4 91 29 30 90
33 4 91 29 30 99
Key Executives for HalioDx SAS
HalioDx SAS Key Developments
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
January 16, 2018
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact HalioDx SAS, please visit www.haliodx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.